Clinical data was reported for the first time in patients receiving an 8 mg dose per injection (Cohort 9 of the dose escalation portion of RESOLVE), the highest dose planned in this trial. Patients in ...
Designed to unlock potential value by creating two independent, publicly traded companies with different business objectives and opportunitiesUpon completion, the royalty management company will manag ...
Alice Liu's leadership is a catalyst for energizing the industry through innovation, collaboration, and empowerment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback